Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression

Proceedings of the National Academy of Sciences of the United States of America

Volumn 97, Issue 23, 2000, Pages 12852-12857

  Thorsell, A ^a   Michalkiewicz, M ^b   Dumont, Y ^c   Quirion, R ^c   Caberlotto, L ^a   Rimondini, R ^a   Mathe A A ^d   Heilig, M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d ST GÖRAN S HOSPITAL   (Sweden)

Author keywords

Amygdala; Anxiety

Indexed keywords

MESSENGER RNA; NEUROPEPTIDE Y;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; FEAR; GENE OVEREXPRESSION; HIPPOCAMPUS; IMMOBILIZATION STRESS; LEARNING; MAZE TEST; NONHUMAN; PEPTIDE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA ANALYSIS; SPATIAL MEMORY; TRANSGENIC ANIMAL;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS;

EID: 0033732324     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.220232997     Document Type: Article

References (48)

1. Tatemoto, K., Carlquist, M. & Mutt, V. (1982) Nature (London) 296, 659-660.
2. Heilig, M., Söderpalm, B., Engel, J. A. & Widerlöv, E. (1989) Psychopharmacology 98, 524-529.
3. Heilig, M., McLeod, S., Brot, M., Heinrichs, S. C., Menzaghi, F., Koob, G. F. & Britton, K. T. (1993) Neuropsychopharmacology 8, 357-363.
4. Broqua, P., Wettstein, J. G., Rocher, M. N., Gauthier-Martin, B. & Junien, J. L. (1995) Behav. Pharmacol. 6, 215-222.
5. Sajdyk, T. J., Vandergriff, M. G. & Gehlert, D. R. (1999) Eur. J. Pharmacol. 368, 143-147.
6. Eva, C., Keinanen, K., Monyer, H., Seeburg, P. & Sprengel, R. (1990) FEBS Lett. 271, 81-84.
7. Herzog, H., Hort, Y. J., Ball, H. J., Hayes, G., Shine, J. & Selbie, L. A. (1992) Proc. Natl. Acad. Sci. USA 89, 5794-5798.
8. Larhammar, D., Blomqvist, A. G., Yee, F., Jazin, E., Yoo, H. & Wahlestedt, C. (1992) J. Biol. Chem. 267, 10935-10938.
9. Wahlestedt, C., Pich, E. M., Koob, G. F., Yee, F. & Heilig, M. (1993) Science 259, 528-531.
10. Heilig, M. (1995) Regul. Pept. 59, 201-205.
11. Sheikh, S. P., Håkansson, R. & Schwartz, T. W. (1989) FEBS Lett. 245, 209-214.
12. McOuiston, A. R. & Colmers, W. F. (1996) J. Neurophysiol. 76, 3159-3168.
13. Qian, J., Colmers, W. F. & Saggau, P. (1997) J. Neurosci. 17, 8169-8177.
14. Möller, C., Wiklund, L., Sommer, W., Thorsell, A. & Heilig, M. (1997) Brain Res. 760, 94-101.
15. Thorseil, A., Carlsson, K., Ekman, R. & Heilig, M. (1999) NeuroReport 10, 3003-3007.
16. Heilig, M., Koob, G. F., Ekman, R. & Britton, K. T. (1994) Trends Neurosci. 17, 80-85.
17. Thiele, T. E., Marsh, D. J., Ste, M., Bernstein, I. L. & Palmiter, R. D. (1998) Nature (London) 396, 366-369.
18. Larhammar, D., Ericsson, A. & Persson, H. (1986) Proc. Natl. Acad. Sci. USA 84, 2068-2072.
19. Morris, R. G. (1981) Learn. Motivat. 12, 239-260.
20. Michalkiewicz, M. (2000) in Methods in Molecular Biology: Neuropeptide Y Protocols, ed. Balasubramaniam, A. A. (Humana Press, Totowa, NJ).
21. Pellow, S., Chopin, P., File, S. E. & Briley, M. (1985)J. Neurosci. Methods 14, 149-167.
22. Pellow, S. & File, S. E. (1986) Pharmacol. Biochem. Behav. 24, 525-529.
23. Handley, S. L. & McBlane, J. W. (1993) J. Pharmacol. Toxicol. Methods 29, 129-138.
24. Pham, T. M., Söderstrom, S., Henriksson, B. G. & Mohammed, A. H. (1997) Behav. Brain Res. 86, 113-120.
25. Caberlotto, L., Fuxe, K., Overstreet, D. H., Gerrard, P. & Hurd, Y. L. (1998) Brain Res. Mol. Brain Res. 59, 58-65.
26. Michalkiewicz, M., Huffman, L. J., Dey, M. & Hedge, G. A. (1993) Am. J. Physiol. 264, E699-E705.
27. Dumont, Y., Cadieux, A., Doods, H., Pheng, L. H., Abounader, R., Hamel, E., Jacques, D., Regoli, D. & Quirion, R. (2000) Br. J. Pharmacol. 129, 1075-1088.
28. Dumont, Y. & Quirion, R. (2000) Br. J. Pharmacol. 129, 37-46.
29. Oler, J. A. & Markus, E. J. (1998) Hippocampus 8, 402-415.
30. Miyagawa, H., Hasegawa, M., Fukuta, T., Amano, M., Yamada, K. & Nabeshima, T. (1998) Behav. Brain Res. 91, 73-81.
31. Umezu, T. (1999) Jpn. J. Pharmacol. 80, 111-118.
32. McCreary, A. C., McBlane, J. W., Spooner, H. A. & Handley, S. L. (1996) Pol. J. Pharmacol. 48, 1-12.
33. File, S. E. (1993) Behav. Brain Res. 58, 199-202.
34. Heilig, M., McLeod, S., Koob, G. F. & Britton, K. T. (1992) Regul. Pept. 41, 61-69.
35. Heilig, M. & Murison, R. (1987) Eur. J. Pharmacol. 137, 127-129.
36. Kask, A., Rago, L. & Harro, J. (1996) Eur. J. Pharmacol. 317, R3-R4.
37. Nussdorfer, G. G. & Gottardo, G. (1998) Horm. Metab. Res. 30, 368-373.
38. Koob, G. F., Heinrichs, S. C., Pich, E. M., Menzaghi, F., Baldwin, H., Miczek, K. & Britton, K. T. (1993) Ciba Found. Symp. 172, 277-289.
39. Palmiter, R. D., Erickson, J. C., Hollopeter, G., Baraban, S. C. & Schwartz, M. W. (1998) Recent Prog. Horm. Res. 53, 163-199.
40. Crawley, J. N. (2000) What's Wrong with My Mouse: Behavioral Phenotyping of Transgenic and Knockout Mice (Wiley, New York).
41. Vizi, E. S. & Kiss, J. P. (1998) Hippocampus 8, 566-607.
42. Colmers, W. F., Lukowiak, K. & Pittman, Q. J. (1988) J. Neurosci. 8, 3827-3837.
43. Whittaker, E., Vereker, E. & Lynch, M. A. (1999) Brain Res. 827, 229-233.
44. Shimizu, K., Matsubara, K., Uezono, T., Kimura, K. & Shiono, H. (1998) Neuroscience 83, 701-706.
45. Andrews, N., File, S. E., Fernandes, C., Gonzalez, L. E. & Barnes, N. M. (1997) Psychopharmacology 130, 228-234.
46. Gonzalez, L. E., File, S. E. & Overstreet, D. H. (1998) Pharmacol. Biochem. Behav. 59, 787-792.
47. Chojnacka-Wojcik, E., Tatarczynska, E. & Pilc, A. (1997) Eur. J. Pharmacol. 319, 153-156.
48. Woldbye, D. P., Larsen, P. J., Mikkelsen, J. D., Klemp, K., Madsen, T. M. & Bolwig, T. G. (1997) Nat. Med. 3, 761-764.